Processa Pharmaceuticals, Inc.
PCSA
$0.224
$0.0062.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 139.43% | 143.19% | -58.80% | -48.10% | -37.55% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -78.14% | 26.16% | -64.95% | 2.09% | 122.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 90.37% | 100.57% | -61.27% | -35.30% | -23.70% |
|
|
|||||
| Total Current Assets | 90.37% | 100.57% | -61.27% | -35.30% | -23.70% |
| Net Property, Plant & Equipment | -45.33% | -30.65% | -23.15% | -16.17% | -15.41% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -21.94% | 23,172.73% | 0.00% | 0.00% |
| Total Assets | 70.11% | 48.94% | -34.66% | -34.98% | -23.57% |
|
|
|||||
| Total Accounts Payable | 42.20% | -37.27% | 23.77% | -25.33% | 109.29% |
| Total Accrued Expenses | 85.57% | 17.63% | 40.19% | -18.32% | 8.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -48.49% | -31.92% | -22.91% | 1.61% | 3.90% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 61.70% | -16.29% | 25.71% | -21.43% | 53.53% |
|
|
|||||
| Total Current Liabilities | 61.70% | -16.29% | 25.71% | -21.43% | 53.53% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -77.27% | -91.41% | -49.51% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 61.70% | -16.31% | 25.52% | -22.56% | 48.61% |
|
|
|||||
| Common Stock & APIC | 6.94% | 5.23% | 0.80% | 1.24% | 0.17% |
| Retained Earnings | -4.37% | -3.25% | -3.23% | -4.17% | -3.85% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 73.18% | 107.91% | -54.41% | -38.23% | -32.19% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 73.18% | 107.91% | -54.41% | -38.23% | -32.19% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 73.18% | 107.91% | -54.41% | -38.23% | -32.19% |
|
|
|||||